Latest & greatest articles for nitroglycerin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on nitroglycerin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on nitroglycerin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for nitroglycerin

1. Nitroglycerin

Nitroglycerin Top results for nitroglycerin - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for nitroglycerin The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

2. Efficacy of egg yolk and nitroglycerin ointment as treatments for acute anal fissures: A randomized clinical trial study.

Efficacy of egg yolk and nitroglycerin ointment as treatments for acute anal fissures: A randomized clinical trial study. 27957300 2016 12 13 2017 02 24 8 10 2016 Oct Electronic physician Electron Physician Efficacy of egg yolk and nitroglycerin ointment as treatments for acute anal fissures: A randomized clinical trial study. 3035-3041 Acute anal fissure as a common disease in society has several etiologies and manifestations such as severe anal pain and bleeding. Nitroglycerin ointment 0.2 (...) % is the most common topical treatment used. The most common side effect of nitroglycerin is headache, which is annoying for patients and often leads to discontinuation of the drug. Comparison of egg yolk as a natural substance with analgesic and anti-inflammatory properties and minimal side effects with nitroglycerin ointment in the treatment of acute anal fissure. This randomized clinical trial was carried out during a 10-day period in the Gastroenterology clinic of Ghaem Hospital, Mashhad, Iran (year

Electronic physician2016 Full Text: Link to full Text with Trip Pro

3. Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics.

Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected (...) item: 26510043 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 29;373(18):1789. doi: 10.1056/NEJMc1510178. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26510043 DOI: [Indexed for MEDLINE] Free full text Publication types

NEJM2015

4. Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics.

Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected (...) item: 26510044 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 29;373(18):1788-9. doi: 10.1056/NEJMc1510178#SA1. Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26510044 DOI: [Indexed for MEDLINE] Publication types

NEJM2015 Full Text: Link to full Text with Trip Pro

6. Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines

Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation CADTH. Nitroglycerin for the treatment of pulmonary edema following submersion: clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions No relevant health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, or evidence-based guidelines were identified regarding the use

Health Technology Assessment (HTA) Database.2014

7. Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study

Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study 24700403 2014 04 17 2015 09 03 2014 04 17 1496-8975 61 5 2014 May Canadian journal of anaesthesia = Journal canadien d'anesthesie Can J Anaesth Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study. 398-406 10.1007/s12630-014-0131-z We tested the hypothesis that clevidipine (...) , a rapidly acting dihydropyridine calcium channel blocker, is not inferior to nitroglycerin (NTG) in controlling blood pressure before cardiopulmonary bypass (CPB) during coronary artery bypass grafting (CABG). In this double-blind study from October 4, 2003 to April 26, 2004, 100 patients undergoing CABG with CPB were randomized at four centres to receive intravenous infusions of clevidipine (0.2-8 μg·kg(-1)·min(-1)) or NTG (0.4 μg·kg(-1)·min(-1) to a clinician-determined maximum dose rate) from

EvidenceUpdates2014

9. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Transdermal nitroglycerin patches... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1986 ) Volume: 105 , Issue: 4 , Pages: 485-492 PubMed: Available from or Find this paper at: Abstract The duration of effect of transdermal nitroglycerin patches was studied in 14 patients (...) with angina pectoris. By titrating the dose to achieve specific circulatory effects, we chose a patch size that produced a consistent fall in systolic blood pressure of 10 mm Hg or greater for each patient (10 cm2 in 7 patients, 20 cm2 in 5, and 40 cm2 in 2; releasing 5, 10, and 20 mg of nitroglycerin per 24 hours, respectively). The effects of these individualized patches were compared with those of placebo patches. Compared with placebo, nitroglycerin patches increased exercise duration to the onset

Annals of Internal Medicine2013

10. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.

Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Rapidly developing tolerance to t... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1986 ) Volume: 104 , Issue: 3 , Pages: 295-298 PubMed: Available from or Find this paper at: Abstract We have reported early attenuation of hemodynamic effects of transdermal nitroglycerin in patients with heart (...) failure. We now report nitroglycerin plasma levels in those same patients. We administered transdermal nitroglycerin, 60 mg/24 h, to eight patients or placebo to seven patients in a double-blind fashion, and monitored pulmonary wedge pressure and nitroglycerin plasma levels for 24 hours. After placebo administration, nitroglycerin plasma levels and pulmonary wedge pressure remained unchanged. During transdermal nitroglycerin administration, the plasma nitroglycerin level rose from 0.04 0.12 ng/mL

Annals of Internal Medicine2013

11. Rectiv (nitroglycerin) Oinment

Rectiv (nitroglycerin) Oinment Drug Approval Package: Rectiv (nitroglycerin) NDA #021359 Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Rectiv (nitroglycerin) Oinment 0.4% Company: ProStrakan, Inc. Application No.: 021359 Approval Date: 06/21/2011 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) Date

FDA - Drug Approval Package2011

12. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.

Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. 21343579 2011 02 23 2011 02 24 2016 10 17 1538-3598 305 8 2011 Feb 23 JAMA JAMA Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. 800-7 10.1001/jama.2011.176 Nitroglycerin stimulates bone formation and inhibits bone resorption, is inexpensive, and is widely available. Its effects on bone density, bone structure, and bone strength (...) are unknown. To determine if nitroglycerin increases lumbar spine bone mineral density (BMD) and to evaluate changes in hip BMD, bone geometry, and density at the radius and tibia, and markers of bone turnover. A single-center, double-blind, placebo-controlled randomized trial conducted in Toronto, Ontario, Canada, for 24 months starting in November 2005 and completed in March 2010, of 243 postmenopausal women with lumbar spine T scores of between 0 and -2.0 who completed a 1-week run-in period taking

JAMA2011

13. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis

Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis Shao LM, Chen QY, Chen MY, Cai JT CRD summary This well-conducted review concluded that, based on the limitations of the meta-analysis, prophylactic use of nitroglycerin for all patients that undergo endoscopic retrograde cholangiopancreatography was not recommended (...) . These conclusions are likely to be reliable. Authors' objectives To evaluate the effect of prophylactic nitroglycerin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Searching PubMed, EMBASE, the Cochrane Library and Science Citation Index were searched for studies in any language (dates spanned1966 to 2008). Search terms were reported. The 2006 to 2008 proceedings of the American Gastroentological Digestive Disease week and the United European Gastroenterology week

DARE.2010

14. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud`s phenomenon: A randomized, controlled trial

MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud`s phenomenon: A randomized, controlled trial 19248104 2009 03 09 2009 04 27 2013 11 21 0004-3591 60 3 2009 Mar Arthritis and rheumatism Arthritis Rheum. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. 870-7 10.1002/art.24351 Raynaud's phenomenon (RP) affects 3-9% of the general population and >90% of patients with systemic sclerosis (...) . Nitrates are often prescribed for the treatment of RP, but currently available formulations are limited by side effects, particularly headaches, dizziness, and skin irritation. The purpose of this study was to evaluate the tolerability and efficacy of a novel formulation of topical nitroglycerin, MQX-503, in the treatment of RP in an ambulatory setting. We conducted a multicenter, randomized, placebo-controlled study with a 2-week single-blind run-in period to determine baseline severity, followed

EvidenceUpdates2009

15. Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis

Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis Bang UC, Nojgaard C, Andersen PK, Matzen P CRD summary This review supported nitroglycerin use for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis, but concluded that dermal administration did not show beneficial effects and required further (...) investigation. The authors' conclusions appear to reflect the evidence, but given several limitations with the included trials, including insufficient power and potential for bias in the review, the conclusions may not be reliable. Authors' objectives To assess the effectiveness of nitroglycerin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Searching MEDLINE, EMBASE, and the Cochrane Library were searched for relevant articles, and reference lists were handsearched

DARE.2009

16. Randomized comparison of intravenous terbutaline vs nitroglycerin for acute intrapartum fetal resuscitation.

Randomized comparison of intravenous terbutaline vs nitroglycerin for acute intrapartum fetal resuscitation. OBJECTIVE: The purpose of this study was to compare terbutaline and nitroglycerin for acute intrapartum fetal resuscitation. STUDY DESIGN: Women between 32-, 42 weeks' gestation were assigned randomly to 250 microg of terbutaline or 400 microg nitroglycerin intravenously for nonreassuring fetal heart rate tracings in labor. The rate of successful acute intrapartum fetal resuscitation and (...) the maternal hemodynamic changes were compared. Assuming a 50% failure rate in the terbutaline arm, we calculated that a total of 110 patients would be required to detect a 50% reduction in failure in the nitroglycerin group (50% to 25%), with an alpha value of .05, a beta value of .20, and a power of 80%. RESULTS: One hundred ten women had nonreassuring fetal heart rate tracings in labor; 57 women received terbutaline, and 53 women received nitroglycerin. Successful acute resuscitation rates were similar

EvidenceUpdates2007

17. Chest pain relief by nitroglycerin does not predict active coronary artery disease.

Chest pain relief by nitroglycerin does not predict active coronary artery disease. BACKGROUND: The belief that chest pain relief with nitroglycerin indicates the presence of active coronary artery disease is common. However, this hypothesis has not been tested. OBJECTIVE: To define the diagnostic and prognostic value of chest pain relief with nitroglycerin. DESIGN: Prospective observational cohort study. SETTING: Urban community teaching hospital. PATIENTS: 459 consecutive patients with chest (...) pain admitted through the emergency department who received nitroglycerin from emergency services personnel or an emergency department nurse. Follow-up was obtained by telephone contact at 4 months. MEASUREMENTS: Chest pain relief was defined as a decrease of at least 50% in patients' self-reported pain within 5 minutes of the initial dose of sublingual or spray nitroglycerin. Active coronary artery disease was defined as any elevated serum enzyme levels, coronary angiography demonstrating a 70

Annals of Internal Medicine2003

18. Nitroglycerin in septic shock after intravascular volume resuscitation.

Nitroglycerin in septic shock after intravascular volume resuscitation. In patients with septic shock, oxygen consumption is increased, but oxygen delivery and extraction is impaired, partly because of microcirculatory shutdown and shunting. Orthogonal polarisation spectral (OPS) imaging allows visualisation of the microcirculation. We used this technique to assess microcirculatory flow in septic-shock patients who had a mean arterial blood pressure of more than 60 mm Hg and central venous (...) pressure greater than 12 mm Hg. The infusion of 0.5 mg of nitroglycerin intravenously then resulted in a marked increase in microvascular flow on OPS imaging. Improved recruitment of the microcirculation could be a new resuscitation endpoint in septic shock.

Lancet2002

19. Nitroglycerin as a uterine relaxant: a systematic review

Nitroglycerin as a uterine relaxant: a systematic review Nitroglycerin as a uterine relaxant: a systematic review Nitroglycerin as a uterine relaxant: a systematic review Morgan P J, Kung R, Tarshis J Authors' objectives To evaluate the effectiveness of nitroglycerin as a uterine relaxant. Searching The authors searched PubMed (from 1966 to 2001), the Cochrane Controlled Trials Register, the International Journal of Obstetric Anesthesia, and the reference lists of identified articles. They also (...) in the review Randomised controlled trials (RCTs) were eligible for the review. Two of the included studies used a crossover design. Specific interventions included in the review Studies using nitroglycerin as a uterine relaxant were potentially eligible. In the included studies, nitroglycerin was used in obstetrics and gynaecology for induction, version, foetal extraction, pre-eclampsia, tocolysis, cervical dilation, embryo transfer and dysmenorrhoea. The dose and application (intravenous, vaginal or skin

DARE.2002

20. Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom

Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (...) (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom Christie A, Guest J F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of nitroglycerin (0.2% glycerine nitrate, GTN) (Rectogesic) for the treatment

NHS Economic Evaluation Database.2002